Travere Therapeutics (TVTX) Treasury Shares (2013 - 2025)

Travere Therapeutics has reported Treasury Shares for 13 years, with the latest figure at $233604.0 in Q4 2025.

• For the quarter ending Q4 2014, Treasury Shares rose 235.85% year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2014 stood at $3.2 million (up 235.85% YoY), and the FY2014 full-year result was $3.2 million, up 235.85% from the prior year.
• Treasury Shares for Q4 2014 stood at $3.2 million, roughly flat from $3.2 million in the prior quarter.
• The five-year high for Treasury Shares was $3.2 million in Q4 2014, with the low at $957272.0 in Q4 2013.
• Historically, Treasury Shares has averaged $1.7 million across 5 years, with a median of $1.5 million in 2021.
• Annual changes were most pronounced in 2023 — Treasury Shares jumped 1730.04% — and 2025, when it tumbled 93.36%.
• Travere Therapeutics' Treasury Shares stood at $957272.0 in 2013, then surged by 235.85% to $3.2 million in 2014.
• The last three Treasury Shares figures came in at $3.2 million (Q4 2014), $3.2 million (Q3 2014), and $957272.0 (Q4 2013), per Business Quant data.